| P2093 | author name string | Lei Shi | |
| | Dong Liu | |
| | Matthew S. Johnson | |
| | Prisca Honore | |
| | Brett Antonio | |
| | Rosemarie Roeloffs | |
| | Irene Drizin | |
| | Chengmin Zhong | |
| | XuFeng Zhang | |
| | Robert J. Gregg | |
| | Char-Chang Shieh | |
| | Shailen Joshi | |
| | Stephen Werness | |
| | James B. Thomas | |
| | Michael J. Krambis | |
| | Robert N. Atkinson | |
| | Connie R. Faltynek | |
| | Gricelda Simler | |
| | Mark A. Matulenko | |
| | Michael F. Jarvis | |
| | Marc J. C. Scanio | |
| | Michael E. Kort | |
| | Kennan C. Marsh | |
| | Joseph P. Mikusa | |
| | Brian E. Marron | |
| | Matthew A. Secrest | |
| | Ahmed H. Hakeem | |
| | Mark L. Chapman | |
| | Douglas S. Krafte | |
| P2860 | cites work | From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels | Q28143653 |
| | International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels | Q28289125 |
| | The role of voltage-gated sodium channels in neuropathic pain | Q29543085 |
| | Palladium-catalyzed cross-coupling reactions in total synthesis | Q30993316 |
| | Sodium channels, excitability of primary sensory neurons, and the molecular basis of pain | Q33716324 |
| | An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat | Q34239178 |
| | Pyridinylpiperazines, a new class of selective .alpha.2-adrenoceptor antagonists | Q34247765 |
| | Voltage-gated sodium channels and hyperalgesia | Q34292572 |
| | Voltage-gated sodium channel blockers; target validation and therapeutic potential | Q34434328 |
| | A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. | Q34625901 |
| | Voltage-gated sodium channel blockers for the treatment of chronic pain | Q34980986 |
| | New targets for neuropathic pain therapeutics | Q36219689 |
| | Sodium channel blockers | Q36815891 |
| | Voltage-gated sodium channels in pain states: role in pathophysiology and targets for treatment | Q37371254 |
| | Discovery, synthesis, and bioactivity of bis(heteroaryl)piperazines. 1. A novel class of non-nucleoside HIV-1 reverse transcriptase inhibitors | Q42275101 |
| | Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain | Q46821942 |
| | A selective Nav1.8 sodium channel blocker, A-803467 [5-(4-chlorophenyl-N-(3,5-dimethoxyphenyl)furan-2-carboxamide], attenuates spinal neuronal activity in neuropathic rats | Q46843439 |
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | niacinamide | Q192423 |
| P304 | page(s) | 6812-6815 | |
| P577 | publication date | 2010-09-18 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry Letters | Q2709483 |
| P1476 | title | Subtype-selective Na(v)1.8 sodium channel blockers: identification of potent, orally active nicotinamide derivatives | |
| | Subtype-selective Nav1.8 sodium channel blockers: Identification of potent, orally active nicotinamide derivatives | |
| P478 | volume | 20 | |